Fig. 3From: MiR-126, IL-7, CXCR1/2 receptors, inflammation and circulating endothelial progenitor cells: The study on targets for treatment pathways in a model of subclinical cardiovascular disease (type 1 diabetes mellitus)a Receiver Operating Characteristic Curve (ROC) for miR-126-5p in type 1 diabetes and healthy controls; b ROC curve of HbA1c indicating upregulation of miR-126-5p expressionBack to article page